Presented by:
Karen E. Knudsen, Ph.D.
Professor, Cancer Biology, Urology, & Radiation Oncology
Thomas Jefferson University
Deputy Director, Basic Science
Kimmel Cancer Center

Dr. Karen Knudsen's laboratory seeks to understand the extent and impact of alterations in DNA Damage Response pathways in prostate cancer patients will target specific DNA repair problems and allow effective Precision Medicine (tailored treatment regimens) based on molecular subtyping of patient DDR alterations matched to drug therapy. She and her team hope to identify and comprehensively determine the frequency of abiraterone in DDR pathways at different stages of prostate cancer progression.

Light lunch served

Sponsored by the JCCC Genitourinary Oncology Program Area